JAK-IN-32

JAK-IN-32

• CAS Number: 936091-56-4
• UNSPSC Description: JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1].
• Target Antigen: JAK
• Type: Reference compound
• Related Pathways: Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
• Applications: COVID-19-immunoregulation
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/jak-in-32.html
• Solubility: 10 mM in DMSO
• Smiles: CC(C)(NS(C1=CC=CC(NC2=NC(NC3=CC(CN4CCOCC4)=CC=C3)=NC=C2C)=C1)(=O)=O)C
• Molecular Weight: 510.65
• References & Citations: [1]Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported